Anticancer Effects of Sacha Inchi (Plukenetia volubilis) Shell Extract on Colon Cancer Cells: Integrated GC-MS, LC-MS, Transcriptomic, and Proteomic Analyses
Authors:
- Supawadee OsotprasitSOSupawadee Osotprasit
- Saowaros Suwansa-ArdSSSaowaros Suwansa-Ard
- Scott F. CumminsSCScott F. Cummins
- Tianfang WangTWTianfang Wang
- Stuart J. SmithSSStuart J. Smith
- Tepparit SamritTSTepparit Samrit
- Athit ChaiwichienACAthit Chaiwichien
- Narin ChangklungmoaNCNarin Changklungmoa
- Pornanan KueakhaiPKPornanan Kueakhai
Open Access
- 25 December 2025
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (1) , 234
Abstract
With an aging population and the increase in life expectancy, colorectal cancer is becoming increasingly common. Currently, the mainstay of treatment is chemotherapy, which can cause a variety of side effects. However, herbalists in many cultures have long used herbs to promote health and treat various diseases, including colon cancer. This study investigated the chemical components of shell extracts from Plukenetia volubilis (sacha inchi) and their effects on colon cancer cells. First, cytotoxicity against both normal and cancer cells was assessed, followed by cell migration and invasion. Finally, transcriptomic and proteomic analyses were performed to investigate molecular mechanisms. Phytochemical analysis showed a total phenolic content of 134.61 ± 0.27 mgGAE/g extract and a total flavonoid content of 5.75 ± 0.01 mgQE/g extract; moreover, lidocaine (10.57%) and linolenic acid (10.39%) were identified as the most abundant compounds. In vitro, the extract inhibited cell migration, invasion, and colony formation and was associated with potential modulations of the Hippo pathways and epithelial–mesenchymal transition. Therefore, it can be concluded that these extracts are effective in inhibiting the progression of colon cancer cells, and thus, they can prospectively be developed as a dietary supplement or therapeutic agent for the treatment of colon cancer in the future.Keywords
Funding Information
- National Research Council of Thailand (N41A650402)
- TAI.C.M.S. Standard industrial company limited
This publication has 70 references indexed in Scilit:
- Natural compound Byakangelicin suppresses breast tumor growth and motility by regulating SHP-1/JAK2/STAT3 signal pathwayBiochemical and Biophysical Research Communications, 2024
- Echinocystic acid induces the apoptosis, and inhibits the migration and invasion of non-small cell lung cancer cellsMedical Oncology, 2023
- Metabolically stable diphenylamine derivatives suppress androgen receptor and BET protein in prostate cancerBiochemical Pharmacology, 2020
- EMT and MET: necessary or permissive for metastasis?Molecular Oncology, 2017
- Characteristics and Significance of the Pre-metastatic NicheCancer Cell, 2016
- Inhibition of MT1-MMP activity using functional antibody fragments selected against its hemopexin domainThe International Journal of Biochemistry & Cell Biology, 2012
- New facets of matrix metalloproteinases MMP-2 and MMP-9 as cell surface transducers: Outside-in signaling and relationship to tumor progressionBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2012
- Sclareol induces apoptosis in human HCT116 colon cancer cells in vitro and suppression of HCT116 tumor growth in immunodeficient miceApoptosis, 2007
- Fatty acid profiles from forty‐nine plant species that are potential new sources of γ‐linolenic acidJournal of the American Oil Chemists' Society, 2001
- Vascular endothelial groth factor induces tissue factor and matrix metalloproteinase production in endothelial cells: Conversion of prothrombin to thrombin results in progelatininase a activation and cell proliferationInternational Journal of Cancer, 1998